136 related articles for article (PubMed ID: 34927207)
1. Anti-Ro/SS-A antibody is associated with worse pulmonary outcome and reduced overall survival in systemic sclerosis.
Meridor K; Sagy I; Molad Y
Mod Rheumatol; 2022 Oct; 32(6):1086-1093. PubMed ID: 34927207
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of patients with systemic sclerosis positive for anti-SS-A antibody: a cohort study of 156 patients.
Watanabe T; Ototake Y; Akita A; Suzuki M; Kanaoka M; Tamura J; Saigusa Y; Yamaguchi Y
Arthritis Res Ther; 2024 May; 26(1):93. PubMed ID: 38702799
[TBL] [Abstract][Full Text] [Related]
3. The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis.
Kobak S; Oksel F; Aksu K; Kabasakal Y
Int J Rheum Dis; 2013 Feb; 16(1):88-92. PubMed ID: 23441777
[TBL] [Abstract][Full Text] [Related]
4. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
5. Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis.
Campochiaro C; Hoffmann-Vold AM; Avouac J; Henes J; de Vries-Bouwstra J; Smith V; Siegert E; Airò P; Oksel F; Pellerito R; Vanthuyne M; Pozzi MR; Inanc M; Sibilia J; Gabrielli A; Distler O; Allanore Y;
Rheumatology (Oxford); 2023 Jul; 62(7):2483-2491. PubMed ID: 36413079
[TBL] [Abstract][Full Text] [Related]
6. Scleroderma-specific autoantibodies: Should they be included in the diagnostic work-up for Sjögren's syndrome?
Marketos N; Koulouri V; Piperi EP; Georgaki ME; Nikitakis NG; Mavragani CP
Semin Arthritis Rheum; 2022 Aug; 55():152026. PubMed ID: 35623241
[TBL] [Abstract][Full Text] [Related]
7. Clinical and serological hallmarks of systemic sclerosis overlap syndromes.
Pakozdi A; Nihtyanova S; Moinzadeh P; Ong VH; Black CM; Denton CP
J Rheumatol; 2011 Nov; 38(11):2406-9. PubMed ID: 21844148
[TBL] [Abstract][Full Text] [Related]
8. Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis.
Bournia VK; Diamanti KD; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Res Ther; 2010; 12(2):R47. PubMed ID: 20302639
[TBL] [Abstract][Full Text] [Related]
9. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
[TBL] [Abstract][Full Text] [Related]
10. Impact of double positive for anti-centromere and anti-SS-a/Ro antibodies on clinicopathological characteristics of primary Sjögren's syndrome: a retrospective cohort study.
Suzuki Y; Fujii H; Nomura H; Mizushima I; Yamada K; Yamagishi M; Kawano M
Mod Rheumatol; 2018 Sep; 28(5):872-878. PubMed ID: 29251022
[TBL] [Abstract][Full Text] [Related]
11. Absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: a multicenter study of 689 patients.
Massie C; Hudson M; Tatibouet S; Steele R; Huynh T; Fritzler MJ; Baron M; Pineau CA;
Semin Arthritis Rheum; 2014 Dec; 44(3):338-44. PubMed ID: 25128430
[TBL] [Abstract][Full Text] [Related]
12. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
13. Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality.
De Almeida Chaves S; Porel T; Mounié M; Alric L; Astudillo L; Huart A; Lairez O; Michaud M; Prévot G; Ribes D; Sailler L; Gaches F; Adoue D; Pugnet G
Arthritis Res Ther; 2021 Dec; 23(1):295. PubMed ID: 34876194
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis.
Fujimoto M; Shimozuma M; Yazawa N; Kubo M; Ihn H; Sato S; Tamaki T; Kikuchi K; Tamaki K
Ann Rheum Dis; 1997 Nov; 56(11):667-70. PubMed ID: 9462169
[TBL] [Abstract][Full Text] [Related]
15. Sjogren's syndrome is associated with and not secondary to systemic sclerosis.
Salliot C; Mouthon L; Ardizzone M; Sibilia J; Guillevin L; Gottenberg JE; Mariette X
Rheumatology (Oxford); 2007 Feb; 46(2):321-6. PubMed ID: 16877466
[TBL] [Abstract][Full Text] [Related]
16. Role of the mTOR pathway in minor salivary gland changes in Sjogren's syndrome and systemic sclerosis.
Soypaçacı Z; Gümüş ZZ; Çakaloğlu F; Özmen M; Solmaz D; Gücenmez S; Gercik Ö; Akar S
Arthritis Res Ther; 2018 Aug; 20(1):170. PubMed ID: 30075746
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of usefulness of Polycheck method in the detection autoantibodies in patients with systemic lupus erythematosus, Sjögren's syndrome and systemic sclerosis].
Dryglewskal M; Majdan M; Koszarny A; Grytal A; Grzywnowicz M
Wiad Lek; 2015; 68(3):252-8. PubMed ID: 26753209
[TBL] [Abstract][Full Text] [Related]
18. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
[TBL] [Abstract][Full Text] [Related]
19. Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology.
De Angelis R; Giuggioli D; Bajocchi G; Dagna L; Zanframundo G; Foti R; Cacciapaglia F; Cuomo G; Ariani A; Rosato E; Guiducci S; Girelli F; Riccieri V; Zanatta E; Bosello S; Cavazzana I; Ingegnoli F; Santis M; Murdaca G; Abignano G; Romeo N; Della Rossa A; Caminiti M; Iuliano A; Ciano G; Beretta L; Bagnato G; Lubrano E; De Andres I; Giollo A; Saracco M; Agnes C; Lumetti F; Spinella A; Magnani L; Campochiaro C; De Luca G; Codullo V; Visalli E; Masini F; Gigante A; Bellando-Randone S; Pellegrino G; Pigatto E; Dall'Ara F; Lazzaroni MG; Generali E; Mennillo G; Barsotti S; Mariano GP; Calabrese F; Furini F; Vultaggio L; Parisi S; Peroni CL; Risa AM; Rozza D; Zanetti A; Carrara G; Landolfi G; Scirè CA; Bianchi G; Fusaro E; Sebastiani GD; Govoni M; D'Angelo S; Cozzi F; Doria A; Iannone F; Salvarani C; Matucci-Cerinic M; Ferri C;
J Rheumatol; 2022 Feb; 49(2):176-185. PubMed ID: 34782448
[TBL] [Abstract][Full Text] [Related]
20. Anti-Ro(SS-A) HLA-DR3-positive women: the interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients.
Provost TT; Watson R
J Invest Dermatol; 1993 Jan; 100(1):14S-20S. PubMed ID: 8423383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
